Triple-Negative Breast Cancer: Adjuvant Therapeutic Options

Por Gucalp, Ayca, Traina, Tiffany A.
Publicado em 2011

Targeting the androgen receptor in triple negative breast cancer

Por Gucalp, Ayca, Traina, Tiffany A
Publicado no Curr Probl Cancer (2016)

Palbociclib: an evidence-based review of its potential in the treatment of breast cancer

Por Cadoo, Karen A, Gucalp, Ayca, Traina, Tiffany A
Publicado em 2014

Targeting the androgen receptor in prostate and breast cancer – several new agents in development

Por Proverbs-Singh, Tracy, Feldman, Jarett L., Morris, Michael J., Autio, Karen A., Traina, Tiffany A.
Publicado no Endocr Relat Cancer (2015)

Optimizing Chemotherapy Dose and Schedule by Norton-Simon Mathematical Modeling

Por Traina, Tiffany A., Dugan, Ute, Higgins, Brian, Kolinsky, Kenneth, Theodoulou, Maria, Hudis, Clifford A., Norton, Larry
Publicado em 2010

Decreased gastrointestinal toxicity associated with a novel capecitabine schedule (7 days on and 7 days off): a systematic review

Por Cadoo, Karen A, Gajria, Devika, Suh, Emily, Patil, Sujata, Theodoulou, Maria, Norton, Larry, Hudis, Clifford A, Traina, Tiffany A
Publicado no NPJ Breast Cancer (2016)

Gonadotropin-releasing hormone agonists for ovarian function preservation in premenopausal women undergoing chemotherapy for early stage breast cancer: a systematic review and meta...

Por Munhoz, Rodrigo R., Pereira, Allan A. L., Sasse, André D., Hoff, Paulo M., Traina, Tiffany A., Hudis, Clifford A., Marques, Ricardo J.
Publicado no JAMA Oncol (2016)

Phase II trial of saracatinib (AZD0530), an oral src-inhibitor for the treatment of patients with hormone receptor negative metastatic breast cancer

Por Gucalp, Ayca, Sparano, Joseph A., Caravelli, James, Santamauro, Jean, Patil, Sujata, Abbruzzi, Alyson, Pellegrino, Christine, Bromberg, Jackie, Dang, Chau, Theodoulou, Maria, Massague, Joan, Norton, Larry, Hudis, Clifford, Traina, Tiffany A.
Publicado em 2011

First International TNBC Conference Meeting Report

Por Rida, Padmashree C. G., Ogden, Angela, Ellis, Ian O., Varga, Zsuzsanna, Wolff, Antonio C., Traina, Tiffany A., Hatzis, Christos, Palmer, Julie R., Ambrosone, Christine B., Lehmann, Brian, Nanda, Rita, Rice, Valerie M., Brawley, Otis W., Torres, Mylin A., Rakha, Emad, Aneja, Ritu
Publicado no Breast Cancer Res Treat (2018)

Enzalutamide for the Treatment of Androgen Receptor–Expressing Triple-Negative Breast Cancer

Por Traina, Tiffany A., Miller, Kathy, Yardley, Denise A., Eakle, Janice, Schwartzberg, Lee S., O’Shaughnessy, Joyce, Gradishar, William, Schmid, Peter, Winer, Eric, Kelly, Catherine, Nanda, Rita, Gucalp, Ayca, Awada, Ahmad, Garcia-Estevez, Laura, Trudeau, Maureen E., Steinberg, Joyce, Uppal, Hirdesh, Tudor, Iulia Cristina, Peterson, Amy, Cortes, Javier
Publicado no J Clin Oncol (2018)

Feasibility Trial of Letrozole in Combination With Bevacizumab in Patients With Metastatic Breast Cancer

Por Traina, Tiffany A., Rugo, Hope S., Caravelli, James F., Patil, Sujata, Yeh, Benjamin, Melisko, Michele E., Park, John W., Geneus, Stephanie, Paulson, Matthew, Grothusen, Jill, Seidman, Andrew D., Fornier, Monica, Lake, Diana, Dang, Chau, Robson, Mark, Theodoulou, Maria, Flombaum, Carlos D., Norton, Larry, Hudis, Clifford A., Dickler, Maura N.
Publicado em 2010

Cognitive Impairment in Older Patients With Breast Cancer Before Systemic Therapy: Is There an Interaction Between Cancer and Comorbidity?

Por Mandelblatt, Jeanne S., Stern, Robert A., Luta, Gheorghe, McGuckin, Meghan, Clapp, Jonathan D., Hurria, Arti, Jacobsen, Paul B., Faul, Leigh Anne, Isaacs, Claudine, Denduluri, Neelima, Gavett, Brandon, Traina, Tiffany A., Johnson, Patricia, Silliman, Rebecca A., Turner, R. Scott, Howard, Darlene, Van Meter, John W., Saykin, Andrew, Ahles, Tim
Publicado em 2014

Phase II Trial of Bicalutamide in Patients with Androgen Receptor–Positive, Estrogen Receptor–Negative Metastatic Breast Cancer

Por Gucalp, Ayca, Tolaney, Sara, Isakoff, Steven J., Ingle, James N., Liu, Minetta C., Carey, Lisa A., Blackwell, Kimberly, Rugo, Hope, Nabell, Lisle, Forero, Andres, Stearns, Vered, Doane, Ashley S., Danso, Michael, Moynahan, Mary Ellen, Momen, Lamia F., Gonzalez, Joseph M., Akhtar, Arooj, Giri, Dilip D., Patil, Sujata, Feigin, Kimberly N., Hudis, Clifford A., Traina, Tiffany A.
Publicado em 2013

TBCRC009: A Multicenter Phase II Clinical Trial of Platinum Monotherapy With Biomarker Assessment in Metastatic Triple-Negative Breast Cancer

Por Isakoff, Steven J., Mayer, Erica L., He, Lei, Traina, Tiffany A., Carey, Lisa A., Krag, Karen J., Rugo, Hope S., Liu, Minetta C., Stearns, Vered, Come, Steven E., Timms, Kirsten M., Hartman, Anne-Renee, Borger, Darrel R., Finkelstein, Dianne M., Garber, Judy E., Ryan, Paula D., Winer, Eric P., Goss, Paul E., Ellisen, Leif W.
Publicado no J Clin Oncol (2015)

A Pilot Study of Dose-Dense Paclitaxel With Trastuzumab and Lapatinib for Node-negative HER2-Overexpressed Breast Cancer

Por Iyengar, Neil M., Fornier, Monica N., Sugarman, Steven M., Theodoulou, Maria, Troso-Sandoval, Tiffany A., D’Andrea, Gabriella M., Drullinsky, Pamela R., Gajria, Devika, Goldfarb, Shari B., Comen, Elizabeth A., Lake, Diana E., Modi, Shanu, Traina, Tiffany A., Lacouture, Mario E., Chen, Melanie F., Patil, Sujata, Baselga, José, Norton, Larry, Hudis, Clifford A., Dang, Chau T.
Publicado no Clin Breast Cancer (2015)

Significance of Circulating Tumor Cells in metastatic triple negative breast cancer patients within a randomized, phase II trial: TBCRC 019

Por Paoletti, Costanza, Li, Yufeng, Muñiz, Maria C., Kidwell, Kelley M., Aung, Kimberly, Thomas, Dafydd G., Brown, Martha E., Abramson, Vandana G., Irvin, William J., Lin, Nancy U., Liu, Minetta C., Nanda, Rita, Nangia, Julie R., Storniolo, Anna M., Traina, Tiffany A., Vaklavas, Christos, Van Poznak, Catherine H., Wolff, Antonio C., Forero-Torres, Andres, Hayes, Daniel F.
Publicado no Clin Cancer Res (2015)

OncoKB: A Precision Oncology Knowledge Base

Por Chakravarty, Debyani, Gao, Jianjiong, Phillips, Sarah, Kundra, Ritika, Zhang, Hongxin, Wang, Jiaojiao, Rudolph, Julia E., Yaeger, Rona, Soumerai, Tara, Nissan, Moriah H., Chang, Matthew T., Chandarlapaty, Sarat, Traina, Tiffany A., Paik, Paul K., Ho, Alan L., Hantash, Feras M., Grupe, Andrew, Baxi, Shrujal S., Callahan, Margaret K., Snyder, Alexandra, Chi, Ping, Danila, Daniel C., Gounder, Mrinal, Harding, James J., Hellmann, Matthew D., Iyer, Gopa, Janjigian, Yelena Y., Kaley, Thomas, Levine, Douglas A., Lowery, Maeve, Omuro, Antonio, Postow, Michael A., Rathkopf, Dana, Shoushtari, Alexander N., Shukla, Neerav, Voss, Martin H., Paraiso, Ederlinda, Zehir, Ahmet, Berger, Michael F., Taylor, Barry S., Saltz, Leonard B., Riely, Gregory J., Ladanyi, Marc, Hyman, David M., Baselga, José, Sabbatini, Paul, Solit, David B., Schultz, Nikolaus
Publicado no JCO Precis Oncol (2017)